NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Antigenics Inc. (New York) 

Corporate Headquarters
630 Fifth Avenue, Suite 2100
New York  New York  10111  U.S.A.
Phone: 212-994-8200 Fax: 212-994-8299


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Antigenics Inc. (New York) (AGEN) Cancer Vaccine Gets Negative EU Panel Vote 11/20/2009 8:24:27 AM    More...
Antigenics Inc. (New York) (AGEN) Buoyed by Brain-Cancer Study 10/26/2009 8:03:13 AM    More...
Antigenics Inc. (New York) (AGEN) to Report Third Quarter 2009 Financial Results on October 29, 2009; Conference Call to Follow 10/22/2009 9:40:32 AM    More...
Antigenics Inc. (Lexington, MA) (AGEN) to Raise $10 Million in Private Placement 8/4/2009 7:37:57 AM    More...
Antigenics Inc. (Lexington, MA) (AGEN) to Raise $10 Million in Private Placement 7/31/2009 8:28:34 AM    More...
Antigenics Inc. (New York) (AGEN) to Report Second Quarter 2009 Financial Results on July 30 2009; Conference Call to Follow 7/23/2009 9:46:57 AM    More...
Antigenics Inc. (New York) (AGEN) Regains NASDAQ Compliance 4/30/2009 1:28:44 PM    More...
Antigenics Inc. (New York) (AGEN) Brain Cancer Vaccine Gets Orphan Drug Status 4/29/2009 6:56:29 AM    More...
Antigenics Inc. (New York) (AGEN)’s Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Brain Cancer 3/12/2009 8:45:45 AM    More...
Antigenics Inc. (New York) (AGEN) Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights 2/19/2009 9:02:39 AM    More...
12345678910...